BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31633516)

  • 1. Disparities in the Use of Adjuvant External Beam Radiation Therapy in Node-positive Cervical Cancer Patients Following Hysterectomy.
    Nasioudis D; Musselman K; Gordhandas S; Chapman-Davis E; Frey MK; Caputo TA; Holcomb KM
    Am J Clin Oncol; 2020 Jan; 43(1):43-46. PubMed ID: 31633516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Benefit of Adjuvant Brachytherapy After Hysterectomy With Positive Surgical Margins in Cervical Cancer.
    Li R; Shinde A; Chen YJ; Amini A; Lee S; Dellinger T; Han E; Wakabayashi M; Nelson R; Beriwal S; Glaser S
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):373-382. PubMed ID: 29890264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of adjuvant vaginal vault brachytherapy in early stage cervical cancer patients.
    Bronsart E; Petit C; Gouy S; Bockel S; Espenel S; Kumar T; Fumagalli I; Maulard A; Ayachy RE; Genestie C; Leary A; Pautier P; Morice P; Haie-Meder C; Chargari C
    Cancer Radiother; 2020 Dec; 24(8):860-865. PubMed ID: 33129715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors.
    Nasioudis D; Latif NA; Giuntoli Ii RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Ko EM
    Int J Gynecol Cancer; 2021 Jun; 31(6):829-834. PubMed ID: 33962994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation.
    Ager BJ; Torgeson A; Francis SR; Burt LM; Gaffney DK; Cannon DM
    Am J Clin Oncol; 2020 Jan; 43(1):35-42. PubMed ID: 31764024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the utilization of adjuvant vaginal cuff brachytherapy and/or external beam radiation treatment in stage I and II endometrial cancer: a surveillance, epidemiology, and end-results study.
    Patel MK; Cote ML; Ali-Fehmi R; Buekers T; Munkarah AR; Elshaikh MA
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):178-84. PubMed ID: 22014953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients.
    Cetina L; Garcia-Arias A; Candelaria M; Cantú D; Rivera L; Coronel J; Bazan-Perkins B; Flores V; Gonzalez A; Dueñas-González A
    World J Surg Oncol; 2009 Feb; 7():19. PubMed ID: 19220882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.
    Trifiletti DM; Swisher-McClure S; Showalter TN; Hegarty SE; Grover S
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1032-44. PubMed ID: 26581141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
    Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
    World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
    Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
    Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of vaginal brachytherapy to external beam radiotherapy in adjuvant therapy for high-risk early-stage cervical cancer: A comparative study.
    Ragab OM; Mehta S; Nusbaum DJ; Shimada M; Brunette LL; Roman LD; Matsuo K
    Brachytherapy; 2022; 21(2):141-150. PubMed ID: 34756697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy.
    Logsdon MD; Eifel PJ
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):763-75. PubMed ID: 10098431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of care in women with high-intermediate risk endometrioid adenocarcinoma in the PORTEC-2 era: A SEER database analysis.
    Zavitsanos PJ; Leonard KL
    Brachytherapy; 2017; 16(1):109-115. PubMed ID: 27780688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
    Eifel PJ; Moughan J; Owen J; Katz A; Mahon I; Hanks GE
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):351-8. PubMed ID: 10030261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data.
    Modh A; Ghanem AI; Burmeister C; Rasool N; Elshaikh MA
    Brachytherapy; 2016; 15(5):554-61. PubMed ID: 27475480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
    Alimena S; Yang DD; Melamed A; Mahal BA; Worley MJ; Feldman S; Elias KM; Orio PF; Lee LJ; King M
    Gynecol Oncol; 2019 Sep; 154(3):595-601. PubMed ID: 31292103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
    Tuipae S; Yanaranop M; Oniem N
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S117-24. PubMed ID: 22619897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative radiotherapy for patients with invasive cervical cancer following treatment with simple hysterectomy.
    Chen SW; Liang JA; Yang SN; Lin FJ
    Jpn J Clin Oncol; 2003 Sep; 33(9):477-81. PubMed ID: 14594942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of early-stage cervical carcinoma by modified (Type II) radical hysterectomy.
    Michalas S; Rodolakis A; Voulgaris Z; Vlachos G; Giannakoulis N; Diakomanolis E
    Gynecol Oncol; 2002 Jun; 85(3):415-22. PubMed ID: 12051867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.